Document Detail

PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR.
MedLine Citation:
PMID:  23062219     Owner:  NLM     Status:  Publisher    
Endothelial dysfunction typical of preeclampsia (PE) is the result of an excessive maternal inflammatory response to pregnancy. We investigated PTX3 in maternal, fetal and placental compartments in complicated pregnancies. Maternal blood samples were collected during the third trimester in 53 PE, 43 IUGR (intrauterine growth restriction) and 50 normal pregnancies. Fetal samples were collected from the umbilical vein in 26 PE, 23 IUGR and 26 normal pregnancies at elective cesarean section. Pattern and site of expression of PTX3 were studied by immunohistochemistry (IHC) on placenta, decidual bed and maternal peritoneum. PE and IUGR pregnancies had significantly higher maternal PTX3 levels compared to normal pregnancies, with IUGR significantly lower than PE. Maternal peritoneum expressed a significantly higher signal in the endothelium of pathological compared to normal pregnancies. The maternal increase of PTX3 correlated with the severity of disease with higher PTX3 concentrations in severe PE. Increased PTX3 levels in PE and IUGR mothers, together with IHC data represent the expression of altered endothelial function on the maternal side. IUGR fetuses had higher PTX3 values than controls and the increase was related to IUGR severity, likely reflecting the hypoxic environment. These data confirm the relevance of PTX3 in support the hypothesis that PE is a disease associated with altered maternal endothelial function. The PTX3 increase in IUGR fetuses deserves further investigation.
V Cozzi; C Garlanda; M Nebuloni; V Maina; A Martinelli; S Calabrese; I Cetin
Related Documents :
20216089 - High-salt diet during pregnancy and angiotensin-related cardiac changes.
15132369 - Characteristics of new-onset ventricular arrhythmias in pregnancy.
21116739 - Hemodynamic and neurohumoral profile in patients with different types of hypertension i...
23279499 - Efficacy of cloprostenol or aglepristone at 21-22 and 35-38 days of gestation for preg...
9386139 - Risk and predictors for pregnancy-related complications in women with heart disease.
9546509 - First-trimester transabdominal fetal echocardiography.
23866489 - Primary pulmonary sarcoma metastasising to the skin during pregnancy.
2507369 - Methods for monitoring follicle maturation decrease; the ovarian hyperstimulation syndr...
17211969 - Screening of foetal distress by assessment of umbilical cord lactate.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-9
Journal Detail:
Title:  Placenta     Volume:  -     ISSN:  1532-3102     ISO Abbreviation:  Placenta     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8006349     Medline TA:  Placenta     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Ltd. All rights reserved.
Unit of Obstetrics and Gynecology and Center for Fetal Research Giorgio Pardi, Department of Biomedical and Clinical Sciences "L. Sacco", University of Milan, Via G.B. Grassi 74, 20151 Milano, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Outcome of ELGANS after a protocol to assist preterm infants in their transition to extrauterine lif...
Next Document:  A scoping review identifying contemporary issues in rural nursing leadership.